| Home > Publications database > Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy. > Access to Fulltext |
s41467-026-71608-4-1
|
|||||||
| version 1 |
| ||||||